ACMEDI KOREA Co., Ltd. – Trademark Portfolio

Entity Type: 03

ACMEDI KOREA Co., Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include PLAMON and VEGAPLAX.

#611,612-1, 293, Mokdongdong-ro,

Yangcheon-gu Seoul

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VEGAPLAX
VEGAPLAX
Registered 2022
PLAMON
PLAMON
Registered 2019

Trademark Classifications

ACMEDI KOREA Co., Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ACMEDI KOREA Co., Ltd. have?

ACMEDI KOREA Co., Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does ACMEDI KOREA Co., Ltd. file in?

ACMEDI KOREA Co., Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are ACMEDI KOREA Co., Ltd.'s most well-known trademarks?

ACMEDI KOREA Co., Ltd.'s registered trademark portfolio includes well-known marks such as PLAMON and VEGAPLAX. These are among 2 currently registered trademarks in the portfolio.

What is ACMEDI KOREA Co., Ltd.'s trademark registration success rate?

ACMEDI KOREA Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.